EHRA Premium Access

Impact of atrial fibrillation pattern on left atrial appendage closure: insights from the prospective LAARGE registry

Congress Session

About the speaker

Doctor Shinwan Kany

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
1 presentation
0 follower

5 more presentations in this session

Identification of novel biomarkers for predicting atrial fibrillation outcomes in patients with cardiovascular risk factors

Speaker: Miss A. Khashaba (Birmingham, GB)


Sacubitril/valsartan therapy and supraventricular arrhythmias detected through remote monitoring in heart failure patients

Speaker: Associate Professor F. Guerra (Ancona, IT)


RNA-seq profiling of the atrial transcriptome reveals gender-specific patterns and interactions with atrial fibrillation and heart failure

Speaker: Mr D. Balamurali (Maastricht, NL)


Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive fibrosis

Speaker: Mr L. Hopman (Amsterdam, NL)


Prognostic significance of diabetes mellitus in patients with atrial fibrillation

Speaker: Doctor A. Papazoglou (Thessaloniki, GR)


Access the full session

Pathophysiology of atrial fibrillation and beyond I

Speakers: Doctor S. Kany, Miss A. Khashaba, Associate Professor F. Guerra, Mr D. Balamurali, Mr L. Hopman...

About the event


EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Related content

Open Access

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

27 August 2021

ESC Premium Access

Effects of Sacubitril/valsartan compared with ramipril on coronary events after myocardial infarction - Results from the PARADISE-MI Trial

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

This platform is supported by

logo Novo Nordisk